« Back to Record
Citation APA

Lemal, R., Fouquet, G., Terriou, L., Vaes, M., Livideanu, C. B., Frenzel, L., Barete, S., Canioni, D., Lhermitte, L. L. L., Rossignol, J., Arock, M., Dubreuil, P., Lortholary, O., & Hermine, O. (2019). Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS. Journal of Allergy and Clinical Immunology: In Practice. doi:10.1016/j.jaip.2019.03.039


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/291093

Lemal, R., Fouquet, G., Terriou, L., Vaes, M., Livideanu, C. B., Frenzel, L., Barete, S., Canioni, D., Lhermitte, L. L. L., Rossignol, J., Arock, M., Dubreuil, P., Lortholary, O., & Hermine, O. (2019). Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS. Journal of Allergy and Clinical Immunology: In Practice. doi:10.1016/j.jaip.2019.03.039